1215682

Lori Gawron — FEI 3027402421

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 18, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Salt Lake City, UT (United States)

Additional Details

Clinical Investigator (CI)